NeuroSense Therapeutics Ltd. (NRSNW) Stock Price & Growth Analysis

Quote Panel

Updated October 4, 2024

1W -14.29 % 1M -20.00 % 3M -41.18 % 1Y 9.09 %

Key Metrics

Market Cap
20.36M
Shares Outstanding
168.29M
Share in Float
Dividende
0

Earning Date
No Data
Price Target
0.12
Average Volume
Beta
1.499

Range
0.14-0.14
Industry
Biotechnology
Website
https://www.neurosense-tx.com
Sector
Healthcare

Fundamentals

Infinityx

P/E Ratio

0.00x

P/S Ratio

-2.67x

P/B Ratio

-0.0

Debt/Equity

0.0%

Net Margin

$-0.9

EPS

How NRSNW compares to sector?

P/E Ratio

Relative Strength

NRSNW

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings Growth

YoY

Current

Estimates

Q4.21

N/A

NA
vs NA

Q1.22

N/A

NA
vs NA

Q2.22

N/A

NA
vs NA

Q3.22

N/A

NA
vs NA

Q4.22

N/A

NA
vs NA

Q1.23

N/A

NA
vs NA

Q2.23

N/A

NA
vs NA

Q3.23

N/A

NA
vs NA

Q4.23

N/A

NA
vs NA

Q1.24

N/A

NA
vs NA

Sales Growth

YoY

Current

Estimates

Q4.21

NA vs NA

Q1.22

NA vs NA

Q2.22

NA vs NA

Q3.22

NA vs NA

Q4.22

NA vs NA

Q1.23

NA vs NA

Q2.23

NA vs NA

Q3.23

NA vs NA

Q4.23

NA vs NA

Q1.24

NA vs NA

Return on Equity

QoQ

Q2.22

-34%

-0.34
vs -0.18

Q3.22

-34%

-0.34
vs -0.34

Q4.22

-53%

-0.53
vs -0.34

Q1.23

-132%

-1.32
vs -0.53

Q2.23

+338%

3.38
vs -1.32

Q3.23

-400%

-4.00
vs 3.38

Q4.23

+157%

1.57
vs -4.00

Q1.24

+77%

0.77
vs 1.57

Institutionnal Ownership

QoQ

Q3.22

4
vs 4

Q4.22

4
vs 4

Q1.23

4
vs 4

Q2.23

5
vs 4

25%

Q3.23

6
vs 5

20%

Q4.23

3
vs 6

-50%

Q1.24

4
vs 3

33%

Q2.24

4
vs 4

Company Description

Infinityx

0.00x

-2.67x

-0.0

0.0%

$-0.9

Earnings Growth

Latest News

New Feature Coming Soon, Stay Tuned!